Insights

Posts about:

health technology (2)

CTO-of-The-Year-2018_01-2606x1400

Finland’s CTOs of the Year announced: Vesa Varjonen of Planmeca and Matti Heikkilä of MetGen have contributed to the renewal of Finnish industry

Vesa Varjonen, Vice President of Research and Technology at Planmeca and Matti Heikkilä, CTO of MetGen have been chosen as CTOs of the Year 2018.  The jury consisting of leading Finnish technology influencers emphasized the significant role of the awarded CTOS on renewal of the industry. The CTO of the Year Awards are given by Spinverse together with Technology Industries of Finland and Business Finland to highlight the importance of Chief Technology Officers work on the future competitiveness of Finnish industries. 

Read More
CleverHealth_Network_logo-1-1440x87

Finland to become a leader in digital health technology: CleverHealth Network takes off

There is a growing need worldwide for digital health solutions. A new innovation ecosystem coordinated by HUS (The Hospital District of Helsinki and Uusimaa) called CleverHealth Network, brings together the health technology knowhow, healthcare professionals and the precise healthcare data of HUS. The aim of the CleverHealth Network is a turnover of 11 billion euro and export earnings of 7,7 billion euro for the companies in the ecosystem.

Read More
Picture1

The best European technology leaders awarded

Martin Curley of Intel Corporation, Marcel Wubbolts of Royal DSM and Jonathan O’Halloran of QuantuMDx have been awarded as European CTOs of the Year. All three are inspiring leaders who have paid special attention to sustainability and the creation of strong and broad technology collaboration communities. Based on their foresighted technology leadership, Europe has reached the forefront in three very different industries.

Read More

Bridging the gap for production of nanopharmaceuticals - towards commercialisation of experimental HIV-vaccine

Nine European companies and research institutes combine forces in the NanoPilot-project to create a pilot plant aimed at accelerating the development of nanomedicine by facilitating the production of small clinical batches under Good Manufacturing Practice (GMP). One of the first three nanopharmaceuticals chosen for production in the pilot plant is a promising intranasal HIV vaccine.

Read More

Diagnosing tuberculosis quicker and cheaper with the help of atmospheric pressure plasma technology

Spinverse will team with eight European companies and research institutes in the EU-funded research and innovation project “IP4Plasma” in an effort to fight the second biggest killer among infectious diseases. The aim is to produce a highly sensitive tuberculosis test that will allow a diagnosis within minutes with costs as low as 1€ per test.

Read More